FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 147 filers reported holding FLEXION THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $91,000 | -84.0% | 11,078 | -82.6% | 0.00% | -100.0% |
| Q1 2021 | $570,000 | -37.0% | 63,641 | -18.8% | 0.00% | 0.0% |
| Q4 2020 | $905,000 | -63.3% | 78,414 | -66.9% | 0.00% | -66.7% |
| Q3 2020 | $2,467,000 | -73.3% | 237,010 | -66.3% | 0.00% | -72.7% |
| Q2 2020 | $9,253,000 | +159.3% | 703,679 | +55.2% | 0.01% | +83.3% |
| Q1 2020 | $3,569,000 | -46.2% | 453,494 | +41.4% | 0.01% | -25.0% |
| Q4 2019 | $6,639,000 | -22.0% | 320,707 | -48.4% | 0.01% | -20.0% |
| Q3 2019 | $8,510,000 | +26.9% | 620,943 | +13.9% | 0.01% | +25.0% |
| Q2 2019 | $6,704,000 | +18.1% | 545,057 | +19.8% | 0.01% | +14.3% |
| Q1 2019 | $5,676,000 | +100.2% | 454,853 | +81.6% | 0.01% | +75.0% |
| Q4 2018 | $2,835,000 | +273.5% | 250,402 | +516.9% | 0.00% | +300.0% |
| Q3 2018 | $759,000 | -55.8% | 40,593 | -39.0% | 0.00% | -50.0% |
| Q2 2018 | $1,719,000 | -32.6% | 66,499 | -36.9% | 0.00% | -50.0% |
| Q3 2017 | $2,550,000 | +249.8% | 105,458 | +192.5% | 0.00% | +300.0% |
| Q2 2017 | $729,000 | -51.0% | 36,057 | -34.8% | 0.00% | -66.7% |
| Q1 2017 | $1,488,000 | +254.3% | 55,305 | +150.2% | 0.00% | +200.0% |
| Q4 2016 | $420,000 | -50.8% | 22,100 | -76.2% | 0.00% | -50.0% |
| Q1 2016 | $854,000 | +65.5% | 92,815 | +246.9% | 0.00% | +100.0% |
| Q4 2015 | $516,000 | -31.8% | 26,755 | -47.5% | 0.00% | 0.0% |
| Q3 2015 | $757,000 | – | 50,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|